ASX health stocks have fallen this week as Chemist Warehouse hits the bourse through its merger with Sigma Healthcare. ...

CSL’s vaccine division is suffering as Americans turn away from flu vaccinations, with a “very severe” influenza season ...

Due to the planned CSL transition, Plasma revenue declined 9% in the quarter ... and that's just a function of pay-for-performance and the fact that we're not where we need to be across the ...

We believe CSL's valuation multiple de-rate is onerous considering the growth outlook, particularly for IG therapies. Key risks include: (1) US inflation impacting plasma donor fees, (2 ...

Google Pay and Google Wallet make it simple to make contactless mobile payments. You can waltz into most stores and pay anything using your NFC-enabled smartphone, or ...

Collegiate esports company CSL Esports has become a new division of sports marketing, media, and technology company Playfly Sports. As a result of the deal, CSL Esports will rebrand to Playfly Esports ...

#1. CSL Key milestones: 2007: CSL hit $100 before its 3-for-1 split. 2015: CSL hit $100 (again) 2018: Cracked $200. 2020: First surpassed $300. Note: CSL would technically be above $500 were it not ...

For example, the team at Goldman Sachs has just initiated coverage on the plasma therapies leader with a buy rating and $325.40 price target. It said: Our Buy recommendation for CSL is driven by ...

The Experimental Advanced Superconducting Tokamak (EAST), often referred to as China’s 'artificial sun,' successfully sustained plasma for a record 1,000 seconds, or over 17 minutes. This ...

It said: The last five years have been particularly challenging for CSL, with the business navigating material inflationary pressures to its plasma collections ... it can pay to listen.